Dr. Ryan Cole: NIH Should Fund Research into Rise in Cancer

Since mRNA technology was deployed widely in the COVID-19 vaccines, developers have rapidly accelerated research into more mRNA products. Moderna alone has more than two dozen mRNA products in development.

But is the mRNA platform really the revolutionary breakthrough that its champions claim?

Since early 2021, Cole has been at the forefront of alerting the public to an unusual spike in cancer diagnoses following the widespread adoption of the COVID-19 genetic vaccines.

In this episode, Cole explains the risks he sees with mRNA technology and how he sees things shaking out at the National Institutes of Health and the Centers for Disease Control and Prevention in the coming months and years.

Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.